SRD-5211

N/A

Report date: 2024/11/04 16:56:54

Base Information

Drug NameSRD-5211
Drug Alias NameSRD-5211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine receptor antagonists
TargetsHistamine receptor
Therapy Area/IndicationsUrticaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Pharmaceuticals Holding Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Pharmaceuticals Holding Co LtdBeijing Kexin Bicheng Pharmaceutical Technology Development Co Ltd Harbin Branch
Inactive CompaniesN/A
Active IndicationsUrticaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A